###BASE_URL###
2007-01-03 | permalink
There may be no better example of the promise and pitfalls of so-called personalized medicine -- tailoring treatments to individual genetic traits -- than the test Genomic Health developed for breast-cancer patients like Katherine Young. [...] Despite widespread hopes that mapping the human genome this decade would usher in a flood of drugs for genetically similar patients, few such products have hit the market, largely because of fears that insurers won't cover their cost.
2007-01-03 | permalink
There may be no better example of the promise and pitfalls of so-called personalized medicine -- tailoring treatments to individual genetic traits -- than the test Genomic Health developed for breast-cancer patients like Katherine Young. [...] Despite widespread hopes that mapping the human genome this decade would usher in a flood of drugs for genetically similar patients, few such products have hit the market, largely because of fears that insurers won't cover their cost.
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.